Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Benoît Tournaire"'
Autor:
Emilie Lecomte, Benoît Tournaire, Benjamin Cogné, Jean-Baptiste Dupont, Pierre Lindenbaum, Mélanie Martin-Fontaine, Frédéric Broucque, Cécile Robin, Matthias Hebben, Otto-Wilhelm Merten, Véronique Blouin, Achille François, Richard Redon, Philippe Moullier, Adrien Léger
Publikováno v:
Molecular Therapy: Nucleic Acids, Vol 4, Iss C (2015)
Recent successful clinical trials with recombinant adeno-associated viral vectors (rAAVs) have led to a renewed interest in gene therapy. However, despite extensive developments to improve vector-manufacturing processes, undesirable DNA contaminants
Externí odkaz:
https://doaj.org/article/741f46340a074fda945084019638521d
Autor:
Adrien Leger, Bernard Gjata, Benjamin Cogné, Laetitia van Wittenberghe, Benoît Tournaire, Jean-Baptiste Dupont, Alban Vignaud, Christophe Georger, Romain Durand, Béatrice Marolleau, Richard O. Snyder, Emilie Bertil, Emilie Lecomte, Philippe Moullier
Publikováno v:
Les Cahiers de Myologie. :99-101
Autor:
Benjamin Cogné, Adrien Leger, Benoît Tournaire, Sylvie Saleun, Magalie Penaud-Budloo, Alain Roulet, Philippe Moullier, Pierre Lindenbaum, Eduard Ayuso, Emilie Lecomte, Véronique Blouin, Aurélien Guy-Duché, Céline Lopez-Roques
Publikováno v:
Human gene therapy methods
Human gene therapy methods, New Rochelle, NY : Mary Ann Liebert, 2017, 28 (3), pp.148-162. ⟨10.1089/hgtb.2016.185⟩
Human gene therapy methods, New Rochelle, NY : Mary Ann Liebert, 2017, 28 (3), pp.148-162. 〈10.1089/hgtb.2016.185〉
Human gene therapy methods, 2017, 28 (3), pp.148-162. ⟨10.1089/hgtb.2016.185⟩
Human gene therapy methods, New Rochelle, NY : Mary Ann Liebert, 2017, 28 (3), pp.148-162. ⟨10.1089/hgtb.2016.185⟩
Human gene therapy methods, New Rochelle, NY : Mary Ann Liebert, 2017, 28 (3), pp.148-162. 〈10.1089/hgtb.2016.185〉
Human gene therapy methods, 2017, 28 (3), pp.148-162. ⟨10.1089/hgtb.2016.185⟩
Recombinant adeno-associated viral (rAAV) vectors have proven excellent tools for the treatment of many genetic diseases and other complex diseases. However, the illegitimate encapsidation of DNA contaminants within viral particles constitutes a majo
Autor:
Bernard Gjata, Benoît Tournaire, Alban Vignaud, Christophe Georger, Philippe Moullier, Romain Durand, Adrien Leger, Jean-Baptiste Dupont, Emilie Lecomte, Benjamin Cogné, Richard O. Snyder, Emilie Bertil, Béatrice Marolleau, Laetitia vanWittenberghe
Publikováno v:
Molecular Therapy. 24:S155
Recombinant adeno-associated virus (rAAV)-based vectors are promising tools for the treatment of Duchenne muscular dystrophy (DMD) by gene therapy. Following rAAV injection in murine and canine models of DMD, several groups have reported significant
Autor:
Jean-Baptiste Dupont, Benoit Tournaire, Christophe Georger, Béatrice Marolleau, Laurence Jeanson-Leh, Mireille Ledevin, Pierre Lindenbaum, Emilie Lecomte, Benjamin Cogné, Laurence Dubreil, Thibaut Larcher, Bernard Gjata, Laetitia Van Wittenberghe, Caroline Le Guiner, Magalie Penaud-Budloo, Richard O Snyder, Philippe Moullier, Adrien Léger
Publikováno v:
Molecular Therapy: Methods & Clinical Development, Vol 2, Iss , Pp - (2015)
Preclinical gene therapy strategies using recombinant adeno-associated virus (AAV) vectors in animal models of Duchenne muscular dystrophy have shown dramatic phenotype improvements, but long-lasting efficacy remains questionable. It is believed that
Externí odkaz:
https://doaj.org/article/846a902b7ddb4553bb393762ce9f0d6f